You are here

Review of Antenatal Depression and TMS: Is it a Treatment Option?

×

Warning message

This Grand Rounds Webinar is restricted to registered participants or on-demand registrants. Click the following link to register: Register Here

Presenting: Review of Antenatal Depression and TMS: Is it aTreatment Option?

You’re invited to join the Clinical TMS Society for this installment of our Grand Rounds On-Demand Webinar:
Review of Antenatal Depression and TMS: Is it a Treatment Option? 

Learning objectives: 

  1. Learners will be able to state the risks and benefits of treatment for antenatal depression.
  2. Discuss the most updated literature on TMS and antenatal depression.
  3. Explain risks and benefits with pregnant patients with antenatal depression who are interested in TMS.

Format: On-Demand
Release Date: 12/10/2018
Expiration Date: 12/10/2020

Cost: Members: $25 | Non-members $50

Method of Physician Participation:
Learners will listen to each audio self-directed module while following along with the visual slides. Upon completion, each learner will answer evaluation questions to receive their CME Certificate.

Bibliographic Sources: 
Included on speaker slides

Disclosure of Conflict of Interest: 
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco.  All of these relationships were treated as a conflict of interest and have been resolved.  (C7 SCS 6.1-­‐6.2, 6.5)

All individuals in a postition to control the content of CME are listed below.

First Name

Last Name

Commercial Interest: Relationship

Michelle

Cochran

Genomind: Speakers Bureau

Kimberly

Cress

Speaker for Neuronetics & Medical Director of Houston NeuroCare Therapy

Adrianne

Davis

Nothing to disclose

Deborah

Kim

Nothing to disclose

Sheryl

Morgan

Nothing to disclose

Randy

Pardell

Nothing to disclose

 

 


Speaker: Deborah Kim, M.D.
 

Dr. Deborah Kim is a Clinical Associate Professor of Psychiatry at the Perelman School of Medicine at the University of Pennsylvania. She is a perinatal psychiatrist who specializes in the treatment of pregnant and postpartum women. Her NIMH funded research has focused on the use of transcranial magnetic stimulation for depressed, pregnant women as well as the effects of maternal early life adversity on pregnancy and infant outcomes. She is currently in private practice and offers deep TMS to patients with treatment resistant depression. Dr. Kim has been studying TMS for antenatal depression since 2005. She recently published the results of a randomized controlled trial regarding the use of TMS for antenatal depression.

Vertical Tabs

Vertical Tabs

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Clinical TMS Society.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this enduring material activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

To get your CME certificate, go to http://tms.cmecertificateonline.com and choose the Grand Round Review of Antenatal Depression and TMS: Is it a Treatment Option Enduring Material